p53 and angiogenesis in non-small-cell lung cancer: Reply to the letter from Giatromanolaki and Koukourakis

por Fontanini, G
Publicado 1998

Fr-MLV infection induces erythroleukaemia instead of lymphoid leukaemia in mice given pituitary grafts.

por Fontanini, G., Basolo, F., Garzelli, C., Squartini, F., Toniolo, A.
Publicado 1990

bcl-2, p53 and proliferating cell nuclear antigen expression is related to the degree of differentiation in thyroid carcinomas.

por Pollina, L., Pacini, F., Fontanini, G., Vignati, S., Bevilacqua, G., Basolo, F.
Publicado 1996

Apoptosis and proliferation in thyroid carcinoma: correlation with bcl-2 and p53 protein expression.

por Basolo, F., Pollina, L., Fontanini, G., Fiore, L., Pacini, F., Baldanzi, A.
Publicado 1997

Expression of interleukin 6 (IL-6) correlates with oestrogen receptor in human breast carcinoma

por Fontanini, G, Campani, D, Roncella, M, Cecchetti, D, Calvo, S, Toniolo, A, Basolo, F
Publicado 1999

Bcl-2 protein: a prognostic factor inversely correlated to p53 in non-small-cell lung cancer.

por Fontanini, G., Vignati, S., Bigini, D., Mussi, A., Lucchi, M., Angeletti, C. A., Basolo, F., Bevilacqua, G.
Publicado 1995

Tumour necrosis factor- α and transforming growth factor- β are significantly associated with better prognosis in non-small cell lung carcinoma: putative relation with BCL -2-media...

por Boldrini, L, Calcinai, A, Samaritani, E, Pistolesi, F, Mussi, A, Lucchi, M, Angeletti, C A, Basolo, F, Fontanini, G
Publicado 2000

Expression of vascular endothelial growth factor mRNA in non-small-cell lung carcinomas

por Fontanini, G, Boldrini, L, Chinè, S, Pisaturo, F, Basolo, F, Calcinai, A, Lucchi, M, Mussi, A, Angeletti, C A, Bevilacqua, G
Publicado 1999

Treatment with interleukin-2 in malignant pleural mesothelioma: immunological and angiogenetic assessment and prognostic impact

por Alì, G, Boldrini, L, Lucchi, M, Picchi, A, Dell'Omodarme, M, Prati, M C, Mussi, A, Corsi, V, Fontanini, G
Publicado 2009

Defective interleukin six expression and responsiveness in human mammary cells transformed by an adeno 5/SV40 hybrid virus.

por Basolo, F., Fiore, L., Calvo, S., Falcone, V., Conaldi, P. G., Fontanini, G., Caligo, A. M., Merlo, G., Gluzman, Y., Toniolo, A.
Publicado 1996

A high vascular count and overexpression of vascular endothelial growth factor are associated with unfavourable prognosis in operated small cell lung carcinoma

por Fontanini, G, Faviana, P, Lucchi, M, Boldrini, L, Mussi, A, Camacci, T, Mariani, M A, Angeletti, C A, Basolo, F, Pingitore, R
Publicado 2002

Neoangiogenesis and p53 protein in lung cancer: their prognostic role and their relation with vascular endothelial growth factor (VEGF) expression.

por Fontanini, G., Vignati, S., Lucchi, M., Mussi, A., Calcinai, A., Boldrini, L., Chiné, S., Silvestri, V., Angeletti, C. A., Basolo, F., Bevilacqua, G.
Publicado 1997

Prognostic significance of osteopontin expression in early-stage non-small-cell lung cancer

por Boldrini, L, Donati, V, Dell'Omodarme, M, Prati, M C, Faviana, P, Camacci, T, Lucchi, M, Mussi, A, Santoro, M, Basolo, F, Fontanini, G
Publicado 2005

ERCC1/BRCA1 expression and gene polymorphisms as prognostic and predictive factors in advanced NSCLC treated with or without cisplatin

por Tiseo, M, Bordi, P, Bortesi, B, Boni, L, Boni, C, Baldini, E, Grossi, F, Recchia, F, Zanelli, F, Fontanini, G, Naldi, N, Campanini, N, Azzoni, C, Bordi, C, Ardizzoni, A
Publicado 2013

KRAS codon 61, 146 and BRAF mutations predict resistance to cetuximab plus irinotecan in KRAS codon 12 and 13 wild-type metastatic colorectal cancer

por Loupakis, F, Ruzzo, A, Cremolini, C, Vincenzi, B, Salvatore, L, Santini, D, Masi, G, Stasi, I, Canestrari, E, Rulli, E, Floriani, I, Bencardino, K, Galluccio, N, Catalano, V, Tonini, G, Magnani, M, Fontanini, G, Basolo, F, Falcone, A, Graziano, F
Publicado 2009

PD-1 and PD-L1 expression in molecularly selected non-small-cell lung cancer patients

por D'Incecco, A, Andreozzi, M, Ludovini, V, Rossi, E, Capodanno, A, Landi, L, Tibaldi, C, Minuti, G, Salvini, J, Coppi, E, Chella, A, Fontanini, G, Filice, M E, Tornillo, L, Incensati, R M, Sani, S, Crinò, L, Terracciano, L, Cappuzzo, F
Publicado 2015

BRAF and RAS mutations as prognostic factors in metastatic colorectal cancer patients undergoing liver resection

por Schirripa, M, Bergamo, F, Cremolini, C, Casagrande, M, Lonardi, S, Aprile, G, Yang, D, Marmorino, F, Pasquini, G, Sensi, E, Lupi, C, De Maglio, G, Borrelli, N, Pizzolitto, S, Fasola, G, Bertorelle, R, Rugge, M, Fontanini, G, Zagonel, V, Loupakis, F, Falcone, A
Publicado 2015

Prognostic and predictive impact of consensus molecular subtypes and CRCAssigner classifications in metastatic colorectal cancer: a translational analysis of the TRIBE2 study

por Borelli, B., Fontana, E., Giordano, M., Antoniotti, C., Lonardi, S., Bergamo, F., Pietrantonio, F., Morano, F., Tamburini, E., Boccaccino, A., Santini, D., Zucchelli, G., Pella, N., Maiello, E., Passardi, A., Zaniboni, A., Ugolini, C., Fontanini, G., Falcone, A., Nyamundanda, G., Sadanandam, A., Cremolini, C.
Publicado 2021

Integrative molecular analysis of combined small-cell lung carcinomas identifies major subtypes with different therapeutic opportunities

por Simbolo, M., Centonze, G., Ali, G., Garzone, G., Taormina, S., Sabella, G., Ciaparrone, C., Mafficini, A., Grillo, F., Mangogna, A., Volante, M., Mastracci, L., Fontanini, G., Pilotto, S., Bria, E., Infante, M., Capella, C., Rolli, L., Pastorino, U., Milella, M., Milione, M., Scarpa, A.
Publicado 2021